Aclaris Therapeutics Reports First Quarter 2021 Financial Results and Provides a Corporate Update

NEXT STORY
Worldwide Point of Care (POC) Diagnostics Industry 2021 – Flexible Microfluidics to Enable Real-time Assessment of Health
PREV STORY
Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Veterinary Ultrasound Scanners Market to expand at a steady CAGR of 4.2% by 2028 – Future Market Insights

Increasing Zoonosis Cases Fuel the Future Veterinary Ultrasound Scanners Market; Moderate Market Growth Anticipated ...

author_avatar
NASDAQ Market News

High Response and Remission Rates in Anti-TNFα Naïve Patients Treated with Qu Biologics’ Novel Immune Therapy for Crohn’s Disease

VANCOUVER, British Columbia, April 19, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical ...

author_avatar
NASDAQ Market News

ADMA Biologics Granted U.S. Patent for Treating Respiratory Infections

Fourth Patent Issued to the Company in the U.S. Provides Coverage for RI-002 Through ...

author_avatar
NASDAQ Market News